FDA lifts major warnings on hormone replacement therapy

The U.S. Food and Drug Administration (FDA) is eliminating the prominent “black box” warnings on many hormone replacement therapy (HRT) medications, signaling a major shift in how the treatment is viewed for menopausal women.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup